Navigation Links
Leerink in Medical News

Medivation to Present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference

SAN FRANCISCO, May 13 /PRNewswire-FirstCall/ -- Medivation, Inc. (Nasdaq: MDVN ) today announced that David Hung, M.D., president and chief executive officer, will present at the Leerink Swann Novel Cancer Therapeutics Roundtable Conference on Wednesday, May 20 in New York. Dr. Hung will pr...

Caliper Life Sciences to Present at Leerink Swann's 3rd Annual Life Science Tools Roundtable Conference

HOPKINTON, Mass., July 31 /PRNewswire-FirstCall/ -- Caliper Life Sciences, Inc. (Nasdaq: CALP ) today announced that its presentation at the Leerink Swann's Life Science Tools Roundtable Conference in Boston, Massachusetts, will be webcast on Thursday, August 7 at 12:50 p.m. EDT. Kevin Hrusov...

Genomic Health to Participate in Leerink Swann Roundtable Conference

REDWOOD CITY, Calif., March 28 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (Nasdaq: GHDX ) today announced that Steven Shak, M.D., Genomic Health's Chief Medical Officer, will participate in Leerink Swann's Roundtable Conference, Bugs and Drugs: The Future of Molecular Diagnostics, in New ...

Gen-Probe to Webcast Presentation at Leerink Swann Molecular Diagnostics Conference

SAN DIEGO, March 27 /PRNewswire-FirstCall/ -- Gen-Probe Incorporated (Nasdaq: GPRO ) announced today that the Company will present at the Leerink Swann "Bugs and Drugs: The Future of Molecular Diagnostics Roundtable Conference" in New York on April 3, 2008 at approximately 1:20 p.m. Eastern T...

BD to Present at the Leerink Swann Molecular Diagnostics Roundtable Conference

FRANKLIN LAKES, N.J., March 26 /PRNewswire-FirstCall/ -- BD (Becton, Dickinson and Company) (NYSE: BDX ), a global medical technology company, announced today that it would present at the Leerink Swann Molecular Diagnostics Roundtable Conference on Thursday, April 3, 2008 at 10:10 a.m. (ET). ...

MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

...2009, subject to satisfaction of customary closing conditions. Deutsche Bank Securities Inc. is acting as Sole Book-Running Manager for the offering. leerink Swann LLC is acting as Co-Lead Manager and Wedbush PacGrow Life Sciences is acting as Co-Manager. MAP Pharmaceuticals has filed a registration ...

Orexigen(R) Therapeutics Prices Public Offering of Common Stock

...t to satisfaction of customary closing conditions. leerink Swann LLC is acting as sole book-running manager f...ies of which may be obtained, when available, from leerink Swann LLC , Attention: Syndicate Department, One F...l Street, 37th Fl., Boston, MA 02110 or by calling leerink Swann LLC, toll free, at 1-800-808-7525, Ext. 4814...

Orexigen(R) Therapeutics Announces Proposed Public Offering of Common Stock

.... All of the shares are being offered by Orexigen. leerink Swann LLC is acting as sole book-running manager f...tus relating to this offering may be obtained from leerink Swann LLC , Attention: Syndicate Department, One F...l Street, 37th Fl., Boston, MA 02110 or by calling leerink Swann LLC, toll free, at 1-800-808-7525, Ext. 4814...

Inverness Medical Innovations, Inc. Announces Offering of $200 Million of Senior Subordinated Notes

...vestment Bank, Goldman, Sachs & Co. and Banc of America Securities LLC will act as joint book-running managers for the offering. Canaccord Adams, leerink Swann and Stifel Nicolaus will serve as co-managers. The offering will be made under Inverness' shelf registration statement on Form S-3 filed wi...

Alsius Corporation Announces Agreement to Sell Assets to ZOLL Medical Corporation

...g to the business, other intangibles, inventories and fixed assets. The closing of the transaction is subject to customary closing conditions. leerink Swann LLC acted as exclusive financial advisor and delivered an opinion to the board of Alsius as to the fairness of the transaction. William W...
Leerink in Medical Technology

Allon Therapeutics to Present New Data at Leerink Swann Alzheimer's Conference

VANCOUVER, British Columbia--(BUSINESS WIRE)--Apr 3, 2007 - Allon Therapeutics Inc. (TSX:NPC), The Neuro Protection Company(TM), announced today the publication of new preclinical data from additional confirmatory animal studies showing that Allon's product candidate AL-108 significantly reduces th...

Light Sciences Oncology Raises $40.1 Million in Series C Financing

... combined with our substantial cash reserves will allow us to continue to move forward with all aspects of our development plan in a timely manner." leerink Swann LLC acted as exclusive placement agent and exclusive financial advisor in connection with the transaction. About Light Sciences Oncology Lig...
Leerink in Biological Technology

Poniard Pharmaceuticals to Present at the Leerink Swann Oncology Roundtable Conference

SOUTH SAN FRANCISCO, Calif., May 13 /PRNewswire-FirstCall/ -- Poniard Pharmaceuticals, Inc. (Nasdaq: PARD ), a biopharmaceutical company focused on innovative oncology therapies, today announced that Jerry McMahon, Ph.D., chairman and chief executive officer, will provide a corporate overview at...

Cadence Pharmaceuticals' CEO Theodore Schroeder to Present at the Leerink Swann Pain Roundtable Conference on June 23, 2008 in New York

SAN DIEGO, June 17 /PRNewswire-FirstCall/ -- Cadence Pharmaceuticals, Inc. (Nasdaq: CADX ), a biopharmaceutical company focused on in-licensing, developing and commercializing proprietary product candidates principally for use in the hospital setting, announced today that the company's Presid...

Kosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference

HAYWARD, Calif., May 6 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (Nasdaq: KOSN ) announced today that Jane Green, Kosan's Vice President, Corporate Communications, will present at the Leerink Swann Solid Tumors Roundtable Conference in New York at the Grand Hyatt Hotel on Frida...

Cynosure to Present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Conference

WESTFORD, Mass., Sept. 28 /PRNewswire-FirstCall/ -- Cynosure, Inc. (Nasdaq: CYNO ), a leading developer and manufacturer of a broad array of light-based aesthetic treatment systems, today announced that the company will present at the Leerink Swann & Company/MEDACorp Aesthetics Roundtable Con...

Idenix Pharmaceuticals Prices Underwritten Offering of Common Stock

...d Exchange Commission a prospectus supplement with respect to the offering. leerink Swann LLC is acting as sole book-running manager for the offering. ...pplement and accompanying prospectus may be obtained, when available, from leerink Swann LLC, Attention: Syndicate Department, One Federal Street, 37(th) Floo...

Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters

...and commissions and estimated expenses). leerink Swann LLC acted as sole book-running manager for t...g prospectus, copies of which may be obtained from leerink Swann LLC , Attention: Syndicate Department, One F...l Street, 37th Fl., Boston, MA 02110 or by calling leerink Swann LLC, toll free, at 1-800-808-7525, Ext. 4814...

Dendreon Announces Webcast Presentations at Upcoming Investor Conferences

...20 a.m. ET Deutsche Bank Securities 34th Annual Healthcare Conference InterContinental Boston Tuesday, May 19, 2009 4:35 p.m. ET leerink Swann Novel Cancer Therapeutics: Oncology Roundtable The Roosevelt Hotel, New York City Wednesday, May 20, 2009 10:30 a.m. ET The ...

Dendreon Reports First Quarter 2009 Financial Results

...of America / Merrill Lynch 2009 Health Care Conference on May 12, 2009 Deutsche Bank 34th Annual Healthcare Conference on May 19, 2009 leerink Swann Novel Cancer Therapeutics: Roundtable Conference on May 20, 2009 About Dendreon Dendreon Corporation is a biotechnolog...

Pharmasset Announces $45.5 Million Registered Direct Offering of Common Stock

...before deducting the placement agent's fee and estimated offering expenses. leerink Swann LLC served as sole placement agent for the offering. Trout Capital pr... may be obtained at the SEC's website at http://www.sec.gov or by calling leerink Swann, toll free, at 1-800-808-7525, Ext. 4556. About Pharmasset P...

Jazz Pharmaceuticals Announces $26.0 Million Registered Direct Offering

...lose on or about July 21, 2008, subject to satisfaction of customary closing conditions. Lazard Capital Markets LLC served as lead placement agent and leerink Swann LLC served as co-placement agent for the offering. Jazz Pharmaceuticals intends to use the net proceeds from this offering primarily to fund c...
Other Tags
(Date:10/31/2014)... HealthDay Reporter THURSDAY, Oct. 30, ... additional $100 million in the fight against the Ebola outbreak ... the World Bank,s total pledge to more than $500 million, ... to the three hardest-hit countries -- Guinea, Liberia and Sierra ... has increased significantly in recent weeks, but we still have ...
(Date:10/31/2014)... Oct. 30, 2014 (HealthDay News) -- Wearing masks made ... festivities that could be risky for children with asthma, ... association advises parents to be proactive about managing their ... enjoyable. Some of the steps they recommend parents ... and haunted houses are exciting adventures that can lead ...
(Date:10/31/2014)... Steven Reinberg HealthDay ... Leprosy, although quite rare, continues to appear in the United ... new cases are reported in the United States each year, ... said. That compares to about 250,000 cases that occurred worldwide ... times, leprosy is an infectious disease that causes skin sores, ...
(Date:10/31/2014)... — A new report by Milken Institute School ... George Washington University examines the challenge of maintaining ... enrolled in Covered California and who are also ... Services Program (CPSP). The CPSP, whose roots are ... ever developed for low-income pregnant women, makes enriched ...
(Date:10/30/2014)... an institutional patient registry on stereotactic body radiotherapy ... of tumors, for medically inoperable, early stage lung ... 2012, according to research presented today at the ... Symposium is sponsored by the American Society of ... Oncology (ASTRO), the International Association for the Study ...
Breaking Medicine News(10 mins):Health News:World Bank Pledges $100M More to Fight West Africa's Ebola Outbreak 2Health News: Halloween Safety Tips for Kids With Asthma 2Health News:Leprosy Still Occurs in U.S., CDC Reports 2Health News:Leprosy Still Occurs in U.S., CDC Reports 3Health News:Report examines health care challenges for pregnant women enrolled in covered California 2Health News:Sustained local control for medically inoperable, early stage lung cancer patients 2Health News:Sustained local control for medically inoperable, early stage lung cancer patients 3
(Date:10/29/2014)... research presented at the Society for Integrative Oncology ... for the first time that it is possible ... readily available nutritional supplement, AHCC. ... Smith, Pharm.D., associate professor in the Department of ... of Texas Health Science Center at Houston (UTHealth) ...
(Date:10/29/2014)... overwhelming number of chemicals from household and industrial products ... our bodies. But for most of them, scientists have ... they,ve taken the first step toward doing that by ... Their new method is published in the ACS journal ... Wambaugh and colleagues note that the risks to human ...
(Date:10/29/2014)... in German . ... and Peter Schlögelhofer at the Max F. Perutz Laboratories ... University of Vienna dived into the process of meiosis ... display an inversion of the standard meiotic phases. The ... Nature Communications . , Meiosis is the two-step ...
Breaking Biology News(10 mins):HPV infections in women eradicated by AHCC, Japanese mushroom extract 2Meiotic cell division 'the other way round' 2
Other Contents